United States · FDA National Drug Code directory
Fingolimod
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 68382-912_37d21196-e2e4-45ce-a16c-f8e8693c94de
- Product NDC
- 68382-912
- Form
- CAPSULE
- Composition / generic term
- Fingolimod
- Labeler
- Zydus Pharmaceuticals USA Inc.
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20221011
- Source listing expiry
- 20261231
Source-listed ingredients
- FINGOLIMOD HYDROCHLORIDE — .5 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 100 CAPSULE in 1 BOTTLE (68382-912-01) · 68382-912-01
- 30 CAPSULE in 1 BOTTLE (68382-912-06) · 68382-912-06
- 90 CAPSULE in 1 BOTTLE (68382-912-16) · 68382-912-16
- 1 BLISTER PACK in 1 CARTON (68382-912-69) / 7 CAPSULE in 1 BLISTER PACK · 68382-912-69
- 4 BLISTER PACK in 1 CARTON (68382-912-70) / 7 CAPSULE in 1 BLISTER PACK · 68382-912-70
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →